- People
- Offices
- Capabilities
back- Capabilities
- Corporate, Finance and Investments
- back
- Corporate, Finance and Investments
- Overview
- Activist Defense
- Banking and Institutional Finance
- Capital Markets
- Construction and Procurement
- Corporate Governance
- Emerging Companies and Venture Capital
- Employee Benefits and Executive Compensation
- Energy and Infrastructure Projects
- Financial Restructuring
- Global Human Capital and Compliance
- Investment Funds and Asset Management
- Mergers and Acquisitions (M&A)
- Middle East and Islamic Finance and Investment
- Private Credit & Special Situations
- Private Equity
- Public Companies
- Real Estate
- Structured Finance and Securitization
- Tax
- Technology Transactions
- Government Matters
- back
- Government Matters
- Overview
- Antitrust
- Data, Privacy and Security
- Environmental, Health and Safety
- FDA and Life Sciences
- Government Advocacy and Public Policy
- Government Contracts
- Healthcare
- International Trade
- National Security and Corporate Espionage
- Securities Enforcement and Regulation
- Special Matters and Government Investigations
- Trial and Global Disputes
- back
- Trial and Global Disputes
- Overview
- Antitrust
- Appellate, Constitutional and Administrative Law
- Bankruptcy and Insolvency Litigation
- Class Action Defense
- Commercial Litigation
- Construction and Engineering Disputes
- Corporate and Securities Litigation
- E-Discovery
- Intellectual Property
- International Arbitration and Litigation
- Labor and Employment
- Product Liability
- Professional Liability
- Toxic & Environmental Torts
- Industries / Issues
- back
- Industries / Issues
- Automotive, Transportation and Mobility
- Energy
- Financial Services
- Food and Beverage
- Higher Education
- Life Sciences and Healthcare
- Technology
- #MeToo
- Buy American
- COVID-19 Vaccine Rollout
- Crisis Management
- Environmental Agenda
- Environmental, Social and Governance (ESG)
- Focus on Women's Health
- Russia/Ukraine
- Special Purpose Acquisition Companies (SPACs)
- Careers
- News & Insights
- About
- Languages
Peter A. Strotz
News 19 results
In the News · Source: Mealey's Daily News Update - Insurance
In the News · Source: Law360
May 1, 2023
Peter Strotz represents Handa Pharmaceuticals in an antitrust case before a California federal court
In the News · Source: Los Angeles Business Journal
Recognition
May 6, 2022
Law360 Selects Five King & Spalding Partners to Serve on 2022 Editorial Boards
In the News · Source: Los Angeles Business Journal
February 7, 2022
Peter Strotz explains how the pandemic has changed the employment environment
Cases & Deals
In the News · Source: Law360
January 5, 2022
Peter Strotz explains why growth will continue in 2022 for California firms
Recognition
August 30, 2021
Los Angeles Times Names Albert Giang and Peter Strotz to its Business of Law: Legal Visionaries List
In the News · Source: Law360 and Daily Journal
Recognition
June 10, 2021
Legal 500 United States 2021 Ranks King & Spalding Practices Among the Top in the Nation
In the News · Source: Law.com
September 29, 2020
Alex Calfo and Peter Strotz discuss COVID-19 liability. Article also notes the growth of the firm’s Los Angeles office to 70 lawyers today